Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 278,839 | 264,493 | 274,019 | 540,856 | 584,177 |
| Marketable Securities | 494,871 | 358,560 | 468,141 | 392,888 | 335,901 |
| Receivables | 34,174 | 226,396 | 44,510 | 108,285 | 94,962 |
| Inventories | 13,511 | 10,240 | 10,263 | 8,749 | 8,638 |
| Other current assets | 107,663 | 0 | 0 | 0 | 0 |
| TOTAL | $974,590 | $919,512 | $868,028 | $1,128,942 | $1,103,680 |
| Non-Current Assets | |||||
| PPE Net | 49,120 | 129,643 | 133,538 | 138,413 | 285,724 |
| Intangibles | 113,080 | 112,958 | 112,027 | 107,478 | 126,766 |
| Other Non-Current Assets | 43,099 | 174,436 | 179,399 | 185,585 | 196,313 |
| TOTAL | $205,299 | $417,037 | $424,964 | $431,476 | $608,803 |
| Total Assets | $1,179,889 | $1,336,549 | $1,292,992 | $1,560,418 | $1,712,483 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,227 | 50,595 | 34,162 | 41,579 | 57,517 |
| Accrued Expenses | 115,586 | 86,697 | 132,165 | 211,165 | 218,674 |
| Other current liabilities | 189,769 | 132,531 | 142,031 | 219,596 | 281,715 |
| TOTAL | $429,869 | $389,138 | $422,170 | $1,154,416 | $1,180,999 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 104,251 | 113,763 | 108,334 | 675,067 | 613,418 |
| Other Non-Current Liabilities | 507,318 | 458,153 | 483,853 | 529,298 | 488,182 |
| TOTAL | $906,692 | $909,786 | $946,465 | $1,029,843 | $1,057,920 |
| Total Liabilities | $1,336,561 | $1,298,924 | $1,368,635 | $2,184,259 | $2,238,919 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 162,499 | 162,422 | 161,970 | 160,844 | 160,185 |
| Common Shares | 1,648 | 1,645 | 1,642 | 1,619 | 1,616 |
| Retained earnings | -4,585,675 | -4,383,296 | -4,489,804 | -5,008,450 | -4,927,420 |
| Other shareholders' equity | -1,408 | -917 | 1,670 | -22,413 | 3,738 |
| TOTAL | $-156,672 | $37,625 | $-75,643 | $-623,841 | $-526,436 |
| Total Liabilities And Equity | $1,179,889 | $1,336,549 | $1,292,992 | $1,560,418 | $1,712,483 |